Abstract
Background: Polycystic ovary syndrome (PCOS) is the most common female endocrine disorder and is accompanied by metabolic syndrome (MS), a risk factor for cardiovascular disorders.
Objective: To evaluate the effect of Omega 3 on the improvement of some metabolic parameters.
Materials/methods: Sixty women (29±6 years) with PCOS and MS were randomized into two groups: 30 received supplementation with omega-3 (Doppelherz, Activ, Germany), 3g/day (1g per capsule and 3 capsules/day), (180mg Eicosapentaenoic Acid (EPA)/ 120mg Docosahexaenoic Acid DHA per day), and 30 were used as controls. Blood samples were drawn at baseline (T0), 3 weeks (T1) and 6 weeks (T2) after start of treatment. We analysed glycemia, lipid profile, markers of inflammation and oxidative stress.
Results: In omega-3 group compared to control, a reduction (p<0.05) in glucose levels was noted at T1 and T2. C-reactive protein (CRP) concentrations were decreased (-25%) at T2. Oxidative stress remain unchanged, but the activity of superoxide dismutase increased as well as the concentrations of Catalase and thiols at T1 and T2 (p<0.001).
Conclusion: Omega 3 supplementation improves hyperglycemia, inflammation, and antioxidant defense in PCOS women with MS, and may lead to decreased cardiovascular complications.
Keywords: Oxidative status, Inflammation, Metabolic syndrome, Omega 3, Dyslipidemia, Hyperglycemia, Polycystic ovary syndrome.
Graphical Abstract
[1]
Wang R, Mol BW. The Rotterdam criteria for polycystic ovary syndrome: evidence-based criteria? Hum Reprod 2017; 32(2): 261-4.
[http://dx.doi.org/10.1093/humrep/dew287] [PMID: 28119448]
[http://dx.doi.org/10.1093/humrep/dew287] [PMID: 28119448]
[2]
Abdelazim IA, Elsawah WF. Metabolic syndrome among infertile women with polycystic ovary syndrome. Asian Pac J Reprod 2015; 4: 44-8.
[http://dx.doi.org/10.1016/S2305-0500(14)60057-9]
[http://dx.doi.org/10.1016/S2305-0500(14)60057-9]
[3]
Ranasinha S, Joham AE, Norman RJ, et al. The association between Polycystic Ovary Syndrome (PCOS) and metabolic syndrome: a statistical modelling approach. Clin Endocrinol (Oxf) 2015; 83(6): 879-87.
[http://dx.doi.org/10.1111/cen.12830] [PMID: 26052744]
[http://dx.doi.org/10.1111/cen.12830] [PMID: 26052744]
[4]
Faghfoori Z, Fazelian S, Shadnoush M, Goodarzi R. Nutritional management in women with polycystic ovary syndrome: a synthesis study. Diabetes Metab Syndr 2017; 11: 429-32.
[http://dx.doi.org/10.1016/j.dsx.2017.03.030]
[http://dx.doi.org/10.1016/j.dsx.2017.03.030]
[5]
Yang K, Zeng L, Bao T, Ge J. Effectiveness of Omega-3 fatty acid for polycystic ovary syndrome: a systematic review and meta-analysis. Reprod Biol Endocrinol 2018; 16(1): 27.
[http://dx.doi.org/10.1186/s12958-018-0346-x] [PMID: 29580250]
[http://dx.doi.org/10.1186/s12958-018-0346-x] [PMID: 29580250]
[6]
Khani B, Mardanian F, Fesharaki SJ. Omega-3 supplementation effects on polycystic ovary syndrome symptoms and metabolic syndrome. J Res Med Sci 2017; 22: 64.
[http://dx.doi.org/10.4103/jrms.JRMS_644_16] [PMID: 28616051]
[http://dx.doi.org/10.4103/jrms.JRMS_644_16] [PMID: 28616051]
[7]
Innes JK, Calder PC. Marine Omega-3 (N-3) Fatty Acids for Cardiovascular Health: An Update for 2020. Int J Mol Sci 2020; 21(4): 18-21.
[http://dx.doi.org/10.3390/ijms21041362] [PMID: 32085487]
[http://dx.doi.org/10.3390/ijms21041362] [PMID: 32085487]
[8]
Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA 2001; 285(19): 2486-97.
[http://dx.doi.org/10.1001/jama.285.19.2486] [PMID: 11368702]
[http://dx.doi.org/10.1001/jama.285.19.2486] [PMID: 11368702]
[9]
Hidalgo-Mora JJ, García-Vigara A, Sánchez-Sánchez ML, García-Pérez MÁ, Tarín J, Cano A. The Mediterranean diet: A historical perspective on food for health. Maturitas 2020; 132: 65-9.
[http://dx.doi.org/10.1016/j.maturitas.2019.12.002] [PMID: 31883665]
[http://dx.doi.org/10.1016/j.maturitas.2019.12.002] [PMID: 31883665]
[10]
Quintanilha AT, Thomas DD, Swanson M. Protein-lipid interactions within purified and reconstituted cytochrome C reductase and oxidase. Biophys J 1982; 37(1): 68-9.
[http://dx.doi.org/10.1016/S0006-3495(82)84603-1] [PMID: 19431506]
[http://dx.doi.org/10.1016/S0006-3495(82)84603-1] [PMID: 19431506]
[11]
Levine RL, Garland D, Oliver CN, et al. Determination of carbonyl content in oxidatively modified proteins. Methods Enzymol 1990; 186: 464-78.
[http://dx.doi.org/10.1016/0076-6879(90)86141-H] [PMID: 1978225]
[http://dx.doi.org/10.1016/0076-6879(90)86141-H] [PMID: 1978225]
[12]
Marklund S, Marklund G. Involvement of the superoxide anion radical in the autoxidation of pyrogallol and a convenient assay for superoxide dismutase. Eur J Biochem 1974; 47(3): 469-74.
[http://dx.doi.org/10.1111/j.1432-1033.1974.tb03714.x] [PMID: 4215654]
[http://dx.doi.org/10.1111/j.1432-1033.1974.tb03714.x] [PMID: 4215654]
[13]
Góth L. A simple method for determination of serum catalase activity and revision of reference range. Clin Chim Acta 1991; 196(2-3): 143-51.
[http://dx.doi.org/10.1016/0009-8981(91)90067-M] [PMID: 2029780]
[http://dx.doi.org/10.1016/0009-8981(91)90067-M] [PMID: 2029780]
[14]
Sedlak J, Lindsay RH. Estimation of total, protein-bound, and nonprotein sulfhydryl groups in tissue with Ellman’s reagent. Anal Biochem 1968; 25(1): 192-205.
[http://dx.doi.org/10.1016/0003-2697(68)90092-4] [PMID: 4973948]
[http://dx.doi.org/10.1016/0003-2697(68)90092-4] [PMID: 4973948]
[15]
Kazemi Jaliseh H, Ramezani Tehrani F, Behboudi-Gandevani S, et al. Polycystic ovary syndrome is a risk factor for diabetes and prediabetes in middle-aged but not elderly women: a long-term population-based follow-up study. Fertil Steril 2017; 108(6): 1078-84.
[http://dx.doi.org/10.1016/j.fertnstert.2017.09.004] [PMID: 29202960]
[http://dx.doi.org/10.1016/j.fertnstert.2017.09.004] [PMID: 29202960]
[16]
Barber TM, Hanson P, Weickert MO, Franks S. Obesity and Polycystic Ovary Syndrome: Implications for Pathogenesis and Novel Management Strategies. Clin Med Insights Reprod Health 2019; 131179558119874042
[http://dx.doi.org/10.1177/1179558119874042] [PMID: 31523137]
[http://dx.doi.org/10.1177/1179558119874042] [PMID: 31523137]
[17]
Koivuaho E, Laru J, Ojaniemi M, et al. Age at adiposity rebound in childhood is associated with PCOS diagnosis and obesity in adulthood-longitudinal analysis of BMI data from birth to age 46 in cases of PCOS. Int J Obes 2019; 43(7): 1370-9.
[http://dx.doi.org/10.1038/s41366-019-0318-z] [PMID: 30718819]
[http://dx.doi.org/10.1038/s41366-019-0318-z] [PMID: 30718819]
[18]
Gao H, Geng T, Huang T, Zhao Q. Fish oil supplementation and insulin sensitivity: a systematic review and meta-analysis. Lipids Health Dis 2017; 16(1): 131.
[http://dx.doi.org/10.1186/s12944-017-0528-0] [PMID: 28673352]
[http://dx.doi.org/10.1186/s12944-017-0528-0] [PMID: 28673352]
[19]
Phelan N, O’Connor A, Kyaw Tun T, et al. Hormonal and metabolic effects of polyunsaturated fatty acids in young women with polycystic ovary syndrome: results from a cross-sectional analysis and a randomized, placebo-controlled, crossover trial. Am J Clin Nutr 2011; 93(3): 652-62.
[http://dx.doi.org/10.3945/ajcn.110.005538] [PMID: 21270384]
[http://dx.doi.org/10.3945/ajcn.110.005538] [PMID: 21270384]
[20]
Woodman RJ, Mori TA, Burke V, Puddey IB, Watts GF, Beilin LJ. Effects of purified eicosapentaenoic and docosahexaenoic acids on glycemic control, blood pressure, and serum lipids in type 2 diabetic patients with treated hypertension. Am J Clin Nutr 2002; 76(5): 1007-15.
[http://dx.doi.org/10.1093/ajcn/76.5.1007] [PMID: 12399272]
[http://dx.doi.org/10.1093/ajcn/76.5.1007] [PMID: 12399272]
[21]
Rahmani E, Samimi M, Ebrahimi FA, et al. The effects of omega-3 fatty acids and vitamin E co-supplementation on gene expression of lipoprotein(a) and oxidized low-density lipoprotein, lipid profiles and biomarkers of oxidative stress in patients with polycystic ovary syndrome. Mol Cell Endocrinol 2017; 439: 247-55.
[http://dx.doi.org/10.1016/j.mce.2016.09.008] [PMID: 27619403]
[http://dx.doi.org/10.1016/j.mce.2016.09.008] [PMID: 27619403]
[22]
Calder PC. Marine omega-3 fatty acids and inflammatory processes: Effects, mechanisms and clinical relevance. Biochim Biophys Acta 2015; 1851(4): 469-84.
[http://dx.doi.org/10.1016/j.bbalip.2014.08.010] [PMID: 25149823]
[http://dx.doi.org/10.1016/j.bbalip.2014.08.010] [PMID: 25149823]
[23]
Jamilian M, Samimi M, Mirhosseini N, et al. The influences of vitamin D and omega-3 co-supplementation on clinical, metabolic and genetic parameters in women with polycystic ovary syndrome. J Affect Disord 2018; 238: 32-8.
[http://dx.doi.org/10.1016/j.jad.2018.05.027] [PMID: 29859385]
[http://dx.doi.org/10.1016/j.jad.2018.05.027] [PMID: 29859385]
[24]
Barrea L, Arnone A, Annunziata G, et al. Adherence to the Mediterranean Diet, Dietary Patterns and Body Composition in Women with Polycystic Ovary Syndrome (PCOS). Nutrients 2019; 11(10): 2278.
[http://dx.doi.org/10.3390/nu11102278] [PMID: 31547562]
[http://dx.doi.org/10.3390/nu11102278] [PMID: 31547562]
[25]
Faghfoori Z. SiavashFazelian S, Mahdi shadnoush M, Reza Goodarzi R. Nutritional management in women with polycystic ovary syndrome: A review study. Diabetes & Metabolic SyndromeClinical Research & Reviews 2017; S1871-4021(17): 30011-5.
[26]
Douglas CC, Norris LE, Oster RA, Darnell BE, Azziz R, Gower BA. Difference in dietary intake between women with polycystic ovary syndrome and healthy controls. Fertil Steril 2006; 86(2): 411-7.
[http://dx.doi.org/10.1016/j.fertnstert.2005.12.054] [PMID: 16762348]
[http://dx.doi.org/10.1016/j.fertnstert.2005.12.054] [PMID: 16762348]
[27]
Mohammadi M. Oxidative Stress and Polycystic Ovary Syndrome: A Brief Review. Int J Prev Med 2019; 10: 86.
[http://dx.doi.org/10.4103/ijpvm.IJPVM_576_17] [PMID: 31198521]
[http://dx.doi.org/10.4103/ijpvm.IJPVM_576_17] [PMID: 31198521]
[28]
Vona R, Gambardella L, Cittadini C, Straface E, Pietraforte D. Biomarkers of Oxidative Stress in Metabolic Syndrome and Associated Diseases. Oxid Med Cell Longev 2019; 20198267234
[http://dx.doi.org/10.1155/2019/8267234] [PMID: 31191805]
[http://dx.doi.org/10.1155/2019/8267234] [PMID: 31191805]
[29]
Enechukwu CI, Onuegbu AJ, Olisekodiaka MJ, et al. Oxidative stress markers and lipid profiles of polycystic ovary syndrome patients in a Nigerian tertiary hospital. Obstet Gynecol Sci 2019; 62(5): 335-43.
[http://dx.doi.org/10.5468/ogs.2019.62.5.335] [PMID: 31538077]
[http://dx.doi.org/10.5468/ogs.2019.62.5.335] [PMID: 31538077]
[30]
Meital LT, Windsor MT, Perissiou M, et al. Omega-3 fatty acids decrease oxidative stress and inflammation in macrophages from patients with small abdominal aortic aneurysm. Sci Rep 2019; 9(1): 12978.
[http://dx.doi.org/10.1038/s41598-019-49362-z] [PMID: 31506475]
[http://dx.doi.org/10.1038/s41598-019-49362-z] [PMID: 31506475]
Article Metrics
14
1